ORIGINAL RESEARCH
Published on 06 Sep 2022
Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease
doi 10.3389/fendo.2022.961231
- 2,669 views
- 10 citations
- Frontiers in Endocrinology
- Cellular Endocrinology
- Research Topics
- Obesity, Type 2 Diabetes and Metabolic Associated Fatty Liver Disease – Molecular Mechanisms and Therapeutic Targets
Obesity, Type 2 Diabetes and Metabolic Associated Fatty Liver Disease – Molecular Mechanisms and Therapeutic Targets
9,626
Total downloads
27k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 17 Aug 2022
Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP/PKA/CREB pathway
doi 10.3389/fendo.2022.899731
- 4,643 views
- 8 citations
ORIGINAL RESEARCH
Published on 26 Jul 2022
IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism
doi 10.3389/fendo.2022.895593
- 2,622 views
- 10 citations
ORIGINAL RESEARCH
Published on 13 Jul 2022
Sulfated Fucogalactan From Laminaria Japonica Ameliorates β-Cell Failure by Attenuating Mitochondrial Dysfunction via SIRT1–PGC1-α Signaling Pathway Activation
doi 10.3389/fendo.2022.881256
- 2,206 views
- 9 citations
ORIGINAL RESEARCH
Published on 09 Jun 2022
GPHB5 Is a Biomarker in Women With Metabolic Syndrome: Results From Cross-Sectional and Intervention Studies
doi 10.3389/fendo.2022.893142
- 2,317 views
- 4 citations
ORIGINAL RESEARCH
Published on 11 Feb 2022
J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes
doi 10.3389/fendo.2022.815995
- 3,260 views
- 13 citations
ORIGINAL RESEARCH
Published on 07 Dec 2021
Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease
doi 10.3389/fendo.2021.780617
- 3,148 views
- 26 citations
